DUBAI, United Arab Emirates, Dec. 18, 2025 (GLOBE NEWSWIRE) — Development updates often arrive quietly before major transitions. Teams tighten processes, review code, and prepare systems for the next crypto stage. For DeFi projects, these moments matter because they tend to arrive just before wider visibility increases. Mutuum Finance (MUTM) has entered that phase. The […]

(NYSE MKT:AXIL), LOS ANGELES, Dec. 18, 2025 (GLOBE NEWSWIRE) — AXIL Brands, Inc. (NYSE American: AXIL), a leading innovator in hearing protection, enhancement, and audio technology, is excited to announce the upcoming launch of the MX II Series earmuffs. The MX II introduces the company's cutting-edge next-generation SonicShieldX(TM) technology platform, delivering superior hearing protection, sound

MONTREAL, Dec. 18, 2025 (GLOBE NEWSWIRE) — A coalition of nearly 30 civil society and academic organizations is urging the federal government to halt plans announced in the latest budget to weaken Canada's pesticide process, and instead launch a long-overdue public debate and comprehensive reform. The Coalition warns that the proposed changes would reduce protections

LongNosedGoblin is a newly discovered China-aligned Advanced Persistent Threat (APT) group targeting governmental entities in Southeast Asia and Japan, with the goal of cyberespionage. This APT group uses Group Policy to deploy malware across the compromised network, and cloud services (e.g., Microsoft OneDrive and Google Drive) as C&C. One of the group's tools, NosyHistorian, is

LONDON, Dec. 18, 2025 (GLOBE NEWSWIRE) — Global markets approach the end of 2025 in a state of measured restraint rather than relief. Inflation has continued to edge lower across advanced economies, yet interest rates remain firmly in restrictive territory, reinforcing the view that any policy easing will be cautious and uneven. Economic growth has

Candidate selection underscores Confo's ability to rapidly advance differentiated GPCR-targeting therapeutics and its focus on metabolic and endocrine disorders Ghent, Belgium – December 18, 2025 – Confo Therapeutics, a leader in the discovery of novel medicines targeting G-protein coupled receptors (GPCRs), announced today that it has selected CFTX-2034, an SSTR5 agonist, as its new antibody

AXIL Unveils MX II Next Generation Earmuffs Featuring Advanced SonicShieldX(TM) Technology Flagship MX II PRO will be available for preorder in January 2026, with deliveries expected in February 2026 GlobeNewswire December 18, 2025 LOS ANGELES, Dec. 18, 2025 (GLOBE NEWSWIRE) — AXIL Brands, Inc. (NYSE American: AXIL), a leading innovator in hearing protection, enhancement, and

New Chinese group LongNosedGoblin deploys cyberespionage tools in Southeast Asia and Japan, ESET Research discovers GlobeNewswire December 18, 2025 LongNosedGoblin is a newly discovered China-aligned Advanced Persistent Threat (APT) group targeting governmental entities in Southeast Asia and Japan, with the goal of cyberespionage. This APT group uses Group Policy to deploy malware across the compromised

Pan Finance Magazine Announces the Q4 Release and Award Winners of 2025 GlobeNewswire December 18, 2025 LONDON, Dec. 18, 2025 (GLOBE NEWSWIRE) — Global markets approach the end of 2025 in a state of measured restraint rather than relief. Inflation has continued to edge lower across advanced economies, yet interest rates remain firmly in restrictive

Confo Therapeutics Nominates SSTR5 Agonist Antibody CFTX-2034 as Development Candidate for Post-Bariatric Hypoglycemia GlobeNewswire December 18, 2025 Candidate selection underscores Confo's ability to rapidly advance differentiated GPCR-targeting therapeutics and its focus on metabolic and endocrine disorders Ghent, Belgium – December 18, 2025 – Confo Therapeutics, a leader in the discovery of novel medicines targeting G-protein